Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2004-05-12
2008-09-23
Balasubram, Venkataraman (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S235800, C514S255050, C544S331000, C544S122000
Reexamination Certificate
active
07427626
ABSTRACT:
Compounds of the formula (I), and pharmaceutically acceptable salts and in vivo hydrolysable esters thereof are described. Also described are processes for their preparation and their use as medicaments, particularly medicaments for producing a cell cycle inhibitory (anti cell proliferation) effect in a warm blooded animal, such as man.
REFERENCES:
patent: 4983608 (1991-01-01), Effland et al.
patent: 5516775 (1996-05-01), Zimmermann et al.
patent: 5521184 (1996-05-01), Zimmermann
patent: 5610303 (1997-03-01), Kimura et al.
patent: 5739143 (1998-04-01), Adams et al.
patent: 5859041 (1999-01-01), Liverton et al.
patent: 6835726 (2004-12-01), Cushing et al.
patent: 6969714 (2005-11-01), Breault et al.
patent: 2003/0144303 (2003-07-01), Hawley et al.
patent: 2003/0191307 (2003-10-01), Blumenkopf et al.
patent: 2006/0079543 (2006-04-01), Sum et al.
patent: 2231765 (1998-09-01), None
patent: 0135472 (1989-01-01), None
patent: 0363002 (1994-06-01), None
patent: 0379806 (1996-04-01), None
patent: 1056742 (2003-07-01), None
patent: 0945443 (2003-08-01), None
patent: 220630 (2002-03-01), None
patent: WO 91/18887 (1991-12-01), None
patent: WO 92/20642 (1992-11-01), None
patent: WO 95/09847 (1995-04-01), None
patent: WO 95/09851 (1995-04-01), None
patent: WO 95/09852 (1995-04-01), None
patent: WO 95/09853 (1995-04-01), None
patent: WO 95/15952 (1995-06-01), None
patent: WO 96/05177 (1996-02-01), None
patent: WO 96/28427 (1996-09-01), None
patent: WO 96/40143 (1996-12-01), None
patent: WO 97/19065 (1997-05-01), None
patent: WO 97/35856 (1997-10-01), None
patent: WO 97/40017 (1997-10-01), None
patent: WO 97/44326 (1997-11-01), None
patent: WO 97/47618 (1997-12-01), None
patent: WO 98/11095 (1998-03-01), None
patent: WO 98/16230 (1998-04-01), None
patent: WO 98/18782 (1998-05-01), None
patent: WO 98/25619 (1998-06-01), None
patent: WO 98/33798 (1998-08-01), None
patent: WO 98/41512 (1998-09-01), None
patent: WO 98/54093 (1998-12-01), None
patent: WO 98/56788 (1998-12-01), None
patent: WO 99/01136 (1999-01-01), None
patent: WO 99/18096 (1999-04-01), None
patent: WO 99/18942 (1999-04-01), None
patent: WO 99/31073 (1999-06-01), None
patent: WO 99/32121 (1999-07-01), None
patent: WO 99/41253 (1999-08-01), None
patent: WO 99/50250 (1999-10-01), None
patent: WO 99/50251 (1999-10-01), None
patent: WO 00/12485 (2000-03-01), None
patent: WO 00/12486 (2000-03-01), None
patent: WO 00/17202 (2000-03-01), None
patent: WO 00/17203 (2000-03-01), None
patent: WO 00/21926 (2000-04-01), None
patent: WO 00/25780 (2000-05-01), None
patent: WO 00/26209 (2000-05-01), None
patent: WO 00/39101 (2000-07-01), None
patent: WO 00/44750 (2000-08-01), None
patent: WO 00/49018 (2000-08-01), None
patent: WO 00/53595 (2000-09-01), None
patent: WO 00/55161 (2000-09-01), None
patent: WO 00/59892 (2000-10-01), None
patent: WO 00/78731 (2000-12-01), None
patent: WO 01/14375 (2001-03-01), None
patent: WO 0129009 (2001-04-01), None
patent: WO 01/30778 (2001-05-01), None
patent: WO 01/37835 (2001-05-01), None
patent: WO 01/47897 (2001-07-01), None
patent: WO 01/47921 (2001-07-01), None
patent: WO 01/60816 (2001-08-01), None
patent: WO 01/64653 (2001-09-01), None
patent: WO 01/64654 (2001-09-01), None
patent: WO 01/64655 (2001-09-01), None
patent: WO 01/64656 (2001-09-01), None
patent: WO 01/72717 (2001-10-01), None
patent: WO 02/04429 (2002-01-01), None
patent: WO 02/20512 (2002-03-01), None
patent: WO 02/46170 (2002-06-01), None
patent: WO 02/46171 (2002-06-01), None
patent: WO 02/065979 (2002-08-01), None
patent: WO 02/066480 (2002-08-01), None
patent: WO 02/066481 (2002-08-01), None
patent: WO 02/092573 (2002-11-01), None
patent: WO 02/096887 (2002-12-01), None
patent: WO 02/096888 (2002-12-01), None
patent: WO 03/007955 (2003-01-01), None
patent: WO 03/011837 (2003-02-01), None
patent: WO 03/029249 (2003-04-01), None
patent: WO 03/031446 (2003-04-01), None
patent: WO 03/037891 (2003-05-01), None
patent: WO 03/076433 (2003-09-01), None
patent: WO 03/076434 (2003-09-01), None
patent: WO 03/076435 (2003-09-01), None
patent: WO 03/076436 (2003-09-01), None
patent: WO 03/076494 (2003-09-01), None
patent: WO 2004/005283 (2004-01-01), None
patent: WO 2004/043467 (2004-05-01), None
patent: WO 2004/043953 (2004-05-01), None
patent: WO 2004/087698 (2004-10-01), None
patent: WO 2004/087699 (2004-10-01), None
patent: WO 2004/101564 (2004-11-01), None
patent: WO 2005/012298 (2005-02-01), None
patent: WO 2005/037800 (2005-04-01), None
patent: WO 2005/075461 (2005-08-01), None
patent: WO 2005/075468 (2005-08-01), None
patent: WO 2005/113550 (2005-12-01), None
patent: WO 2005/116025 (2005-12-01), None
patent: WO 2006/034872 (2006-04-01), None
patent: WO 2006/044509 (2006-04-01), None
patent: WO 2006/050076 (2006-05-01), None
patent: WO 2006/064251 (2006-06-01), None
patent: WO 2006/075152 (2006-07-01), None
patent: WO 2006/095159 (2006-09-01), None
patent: WO 2007/015064 (2007-02-01), None
patent: WO 2007/036732 (2007-04-01), None
patent: WO 2007/040440 (2007-04-01), None
patent: WO 2007/138268 (2007-12-01), None
patent: WO 2007/138277 (2007-12-01), None
patent: WO 2007/148070 (2007-12-01), None
Wolft Manfred E. “Burger's Medicinal Chemistry, 5ed, Part 1”, John Wiley & Sons, 1995, pp. 975-977.
Banker, G.S. et al, “Modern Pharmaceutices, 3ed.”, Marcel Dekker, New York. 1996, pp. 451 and 596.
Fischer Cell Cycle 3:6, 742-746, 2004.
Malumbres et al., Trends in Biochemical Sciences, 30(11), 630-641, 2005.
Lolli et al., Cell Cycle 4 :4, 572-577, 2005.
Sherr et al., Genes & Development 18, 2699-2711, 2004.
Cecil Textbook of Medicine, edited by Bennet, J.C., and Plum F., 20th edition,vol. 1, 1004-1010, 1996.
Blain, S. et al. “Differential interaction of the cyclin-dependent kinase (Cdk) inhibitor p27kiplwith cyclin A-Cdk2 and cyclin D2-Cdk4” The Journal of Biological Chemistry, 1997, vol. 272, No. 41, pp. 25863-25872.
Boschelli, D. et al. “Synthesis and tyrosine kinase inhibitory activity of a series of 2-amino-8H-pyrido[2,3-d]pyrimidines: identification of potent, selective platelet-derived growth factor receptor tyrosine kinase inhibitors” J. Med. Chem., 1998, vol. 41, pp. 4365-4377.
Deady L. et al. “Reactions of some quinazoline compounds with ethoxymethylenemalonic acid derivatives” J. Heterocyclic Chem., 1989, vol. 26, pp. 161-168.
El-Kerdawy, M. et al. “2,4-Bis(substituted)-5-nitropyrimidines of expected diuretic action” Egypt J. Chem., 1986, 29, vol. 2, No. 2, pp. 247-251.
Fiziol Akt Veshchestva, 1975, 7, pp. 68-72.
Ghosh, D. et al. “2,4-Bis(arylamino)-5-methylpyrimidines as antimicrobial agents” J. Med. Chem., 1967, vol. 10, pp. 974-975.
Ghosh, D., “2,4-Bis(arylamino)-6-methyl pyrimidines as antimicrobial agents” Chemical Abstracts, 1981, vol. 95, No. 11, Columbus, Ohio, US; Abstract No. 97712f; pp. 648; XP002109184 abstract & J. Indian Chem. Soc., 1981, vol. 58, No. 5, pp. 512-513, India.
Schmidt, H. et al. “A convenient synthesis of 2-substituted 4-amino-5-pyrimidinecarbonitriles” J. Heterocyclic Chem., 1987, vol. 24, pp. 1305-1307.
Simone, J. “Oncology: introduction” Bennett, J. Textbook of Medicine, 20th Edition, vol. 1, 1996, pp. 1004-1010.
Volin, M. et al. “Cell cycle implications in the pathogenesis of rheumatoid arthritis” Frontiers in Bioscience, 2000, 5, d594-601.
Zimmermann, J. et al. “Phenylamino-pyrimidine (PAP) derivatives: a new class of potent and selective inhibitors of protein kinase C (PKC)” Arch. Pharm. Pharm. Med. Chem. 1996, 329 (7), pp. 371-376.
Fiziol Akt Veshchestva 7:68-72 (1975) (Translantion enclosed).
AstraZeneca AB
Balasubram Venkataraman
Morgan & Lewis & Bockius, LLP
LandOfFree
2-Anilino-4-(imidazol-5-yl)-pyrimidine derivatives and their... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 2-Anilino-4-(imidazol-5-yl)-pyrimidine derivatives and their..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 2-Anilino-4-(imidazol-5-yl)-pyrimidine derivatives and their... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3981144